[1]
Z. Heleniak, Z. Zdrojewski, P. Wisniewski, L. Bieniaszewski, B. Rutkowski, and A. Debska-Slizien, “The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis”, Curr. Issues Pharm. Med. Sci., vol. 29, no. 4, pp. 180–183, Jan. 2017, doi: 10.1515/cipms-2016-0038.